218 related articles for article (PubMed ID: 10932681)
1. Drug treatment of obesity.
Bray GA
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Apr; 13(1):131-48. PubMed ID: 10932681
[TBL] [Abstract][Full Text] [Related]
2. A concise review on the therapeutics of obesity.
Bray GA
Nutrition; 2000 Oct; 16(10):953-60. PubMed ID: 11054601
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
4. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
5. Obesity: pathophysiology and clinical management.
Gurevich-Panigrahi T; Panigrahi S; Wiechec E; Los M
Curr Med Chem; 2009; 16(4):506-21. PubMed ID: 19199918
[TBL] [Abstract][Full Text] [Related]
6. Modern medical management of obesity: the role of pharmaceutical intervention.
Aronne LJ
J Am Diet Assoc; 1998 Oct; 98(10 Suppl 2):S23-6. PubMed ID: 9787732
[TBL] [Abstract][Full Text] [Related]
7. Anti-obesity drugs.
Proietto J
Med J Aust; 1998 Apr; 168(8):409-12. PubMed ID: 9594954
[No Abstract] [Full Text] [Related]
8. Pharmacotherapy for obesity.
Li M; Cheung BM
Br J Clin Pharmacol; 2009 Dec; 68(6):804-10. PubMed ID: 20002075
[TBL] [Abstract][Full Text] [Related]
9. [Cutting-edge of medicine; the prospects of novel anti-obesity drugs].
Ueno H; Nakazato M
Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):753-9. PubMed ID: 24796150
[No Abstract] [Full Text] [Related]
10. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.
Glazer G
Arch Intern Med; 2001 Aug 13-27; 161(15):1814-24. PubMed ID: 11493122
[TBL] [Abstract][Full Text] [Related]
11. Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.
Koiou E; Tziomalos K; Katsikis I; Delkos D; Tsourdi EA; Panidis D
Hormones (Athens); 2013; 12(4):559-66. PubMed ID: 24457404
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and surgical treatments for obesity.
DeWald T; Khaodhiar L; Donahue MP; Blackburn G
Am Heart J; 2006 Mar; 151(3):604-24. PubMed ID: 16504622
[No Abstract] [Full Text] [Related]
13. Pharmacotherapy for obesity.
Ioannides-Demos LL; Proietto J; McNeil JJ
Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system biogenic amine targets for control of appetite and energy expenditure.
Nelson DL; Gehlert DR
Endocrine; 2006 Feb; 29(1):49-60. PubMed ID: 16622292
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
Halford JC
Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
[TBL] [Abstract][Full Text] [Related]
16. Orlistat (Xenical) in the management of obesity.
Cheah JS
Ann Acad Med Singap; 2000 Jul; 29(4):419-20. PubMed ID: 11056767
[No Abstract] [Full Text] [Related]
17. Orlistat, a new lipase inhibitor for the management of obesity.
Heck AM; Yanovski JA; Calis KA
Pharmacotherapy; 2000 Mar; 20(3):270-9. PubMed ID: 10730683
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacotherapy in the treatment of obesity].
Hamann A
MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2010 Mar; 39(1):69-79. PubMed ID: 20202580
[TBL] [Abstract][Full Text] [Related]
20. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Astrup A; Lundsgaard C
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]